Most patients tolerate tirzepatide very well, but some may experience nausea, constipation, bloating, or fatigue during the first few weeks
A Cross-Sectional Survey of University Students
The FDA approved this once-weekly injection on December 5, 2017, specifically for adults with type 2 diabetes to help regulate blood sugar levels when combined with diet and exercise
The company offers employer-sponsored plans, individual marketplace plans, Medicare Advantage plans, and Medicaid managed care plans
Hlscher C (2022) Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimers and Parkinsons diseases
11 Although not a T2D trial, SELECT (semaglutide) enrolled patients with overweight or obesity (BMI 27 kg/m 2 ) and established CVD